Target intelligence / Profile preview

Clostridioides difficile spore surface antigens (C. diff spore antigens)

Target
C. diff spore antigens
Molecular classification
Bacterial surface protein, Antigen, Other
01

Overview

Clostridioides difficile spore surface antigens are a complex array of proteins and glycoproteins located on the outermost layers of the C. difficile spore, specifically the spore coat and the exosporium (Pizarro-Guajardo et al., 2016). Key antigens include the Bacillus collagen-like protein A1 (BclA1), which is a major component of the exosporium, and various Cde (Clostridium difficile exosporium) and Cot (spore coat) proteins like CdeC and CdeM (Calderón-Romero et al., 2018). These antigens are critical for the spore's structural integrity, its ability to survive harsh environmental conditions, and the initial stages of host colonization, including adherence to intestinal epithelial cells and the initiation of germination (Paredes-Sabja et al., 2014). Because the spore is the primary transmission vehicle and is highly resistant to standard antibiotics, these surface antigens represent vital therapeutic targets for preventing Clostridioides difficile infection (CDI) and its recurrence (Zhu et al., 2018). Current drug development efforts focus on vaccines and monoclonal antibodies, such as the experimental PA-50 antibody, which aim to neutralize the spore's infectivity by blocking adherence or promoting immune-mediated clearance through opsonophagocytosis (Wang et al., 2018). Targeting these antigens provides a strategy to intercept the pathogen before it can transition into the toxin-producing vegetative state that causes clinical disease.

Other names
C. difficile exosporium proteinsSpore coat proteinsBclA1CdeCCdeMCot proteins
02

Mechanism of action

Inhibition of spore adherence to host intestinal epithelium, neutralization of the germination process, and induction of opsonophagocytosis to facilitate immune-mediated clearance of dormant spores.

03

Biological functions

Bacterial sporulationCell adhesionOther
04

Disease associations

Infection
05

Safety considerations

Antigenic variation between different ribotypesPotential for low immunogenicity of carbohydrate-rich surface layersRisk of vaccine-induced inflammatory response
06

Interacting drugs

PA-50 (experimental)

2 more in the full profile.

07

Biomarkers

Anti-spore IgG titersSpore load in stool

Beyond the preview

Go deeper on Clostridioides difficile spore surface antigens (C. diff spore antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile spore surface antigens (C. diff spore antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call